Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis
暂无分享,去创建一个
Xin Lu | Fiona Powrie | Simon Clare | S. Clare | Xin Lu | S. Snapper | S. Sansom | F. Powrie | N. Ilott | Xin Lu | S. Mukhopadhyay | Ludovico Buti | B. Horwitz | Stephen N Sansom | N. West | Scott B Snapper | J. Ermann | Joerg Ermann | Nathan R. West | Fanny Franchini | Subhankar Mukhopadhyay | J. Goettel | G. Ryzhakov | Nicholas E Ilott | Claire Pearson | Grigory Ryzhakov | Nathaniel R West | Samuel J Bullers | Alice Costain | Alun Vaughan-Jackson | Jeremy A Goettel | Bruce H Horwitz | Ludovico Buti | F. Franchini | S. Bullers | Alun Vaughan-Jackson | C. Pearson | A. Costain | Grigory Ryzhakov
[1] Pan Du,et al. lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..
[2] W. Garrett,et al. Severity of innate immune-mediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 (Cdcs1) locus , 2011, Proceedings of the National Academy of Sciences.
[3] J. Samsom,et al. IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine , 2016, Oncotarget.
[4] Shuai Li,et al. TIFA as a crucial mediator for NLRP3 inflammasome , 2016, Proceedings of the National Academy of Sciences.
[5] E. Birney,et al. Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Research.
[6] Jianjun Li,et al. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity , 2015, Science.
[7] M. Neurath,et al. High resolution colonoscopy in live mice , 2006, Nature Protocols.
[8] J. Flanagan,et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.
[9] F. Powrie,et al. Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation , 2012, The Journal of experimental medicine.
[10] T. Meyer,et al. ALPK1 and TIFA dependent innate immune response triggered by the Helicobacter pylori type IV secretion system , 2017, bioRxiv.
[11] J M Ward,et al. Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.
[12] Y. Ko,et al. ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares , 2016, Scientific Reports.
[13] R. Xu,et al. Motor coordination deficits in Alpk1 mutant mice with the inserted piggyBac transposon , 2011, BMC Neuroscience.
[14] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[15] C. Arrieumerlou,et al. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria , 2017, PLoS pathogens.
[16] J. Sundberg,et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Siegmund. Interleukin-18 in intestinal inflammation: friend and foe? , 2010, Immunity.
[18] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[19] J. Sundberg,et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[20] F. Powrie,et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.
[21] Philip R. Cohen,et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. , 1998, Immunity.
[22] M. Neurath,et al. Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis1 , 2006, The Journal of Immunology.
[23] A. Sher,et al. Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation , 2001, Infection and Immunity.
[24] J. Affourtit,et al. Cdcs1 a major colitis susceptibility locus in mice; Subcongenic analysis reveals genetic complexity , 2010, Inflammatory bowel diseases.
[25] Xiaojun Ding,et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose , 2018, Nature.
[26] Richard Bonneau,et al. c-Maf-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont , 2018, Nature.
[27] Timothy L. Tickle,et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.
[28] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[29] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[30] A. Bleich,et al. Mapping colitis susceptibility in mouse models: distal chromosome 3 contains major loci related to Cdcs1. , 2013, Physiological genomics.
[31] J. Inoue,et al. Identification of TIFA as an Adapter Protein That Links Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) to Interleukin-1 (IL-1) Receptor-associated Kinase-1 (IRAK-1) in IL-1 Receptor Signaling* , 2003, The Journal of Biological Chemistry.
[32] C. Arrieumerlou,et al. Innate Recognition of Intracellular Bacterial Growth Is Driven by the TIFA-Dependent Cytosolic Surveillance Pathway. , 2017, Cell reports.
[33] F. Powrie,et al. Innate lymphoid cells drive IL-23 dependent innate intestinal pathology , 2010, Nature.
[34] Nigel J. Saunders,et al. CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms , 2003, The Journal of experimental medicine.
[35] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[36] J. Fox,et al. Fluorogenic PCR-Based Quantitative Detection of a Murine Pathogen, Helicobacter hepaticus , 2001, Journal of Clinical Microbiology.
[37] A. Valdes,et al. Familial aggregation of rheumatoid arthritis and co-aggregation of autoimmune diseases in affected families: a nationwide population-based study , 2017, Rheumatology.
[38] A. Peña,et al. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models. , 2005, Gastroenterology.
[39] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[40] Mario Roederer,et al. SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[41] K. Satoh,et al. Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study , 2013, Journal of Medical Genetics.
[42] William C. Skarnes,et al. WGE: a CRISPR database for genome engineering , 2015, Bioinform..
[43] Hiroaki Kitano,et al. The PANTHER database of protein families, subfamilies, functions and pathways , 2004, Nucleic Acids Res..
[44] Shih-Feng Tsai,et al. ALPK1 genetic regulation and risk in relation to gout. , 2013, International journal of epidemiology.
[45] Zsolt Tulassay,et al. Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature , 2008, Disease markers.
[46] J. Sundberg,et al. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. , 2005, Gastroenterology.
[47] Y. Ko,et al. ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production , 2015, The Journal of Steroid Biochemistry and Molecular Biology.
[48] F. Powrie,et al. Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis , 2008, Immunity.
[49] A. Ryazanov,et al. α-Kinase 1, a New Component in Apical Protein Transport* , 2005, Journal of Biological Chemistry.
[50] Isabelle Cleynen,et al. Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment , 2009, PloS one.